3 Stocks I Saw on T...
Health Care: Drugs
Akorn Inc. (AKRX: NASDAQ)
$13.75 0.45 | 3.38%
06/04/12 - 02:55 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 136.92M | 86.41M | 75.89M | 93.60M |
| Cost of Sales | 51.77M | 37.57M | 54.40M | 63.81M |
| Gross Operating Profit | 85.15M | 48.84M | 21.49M | 29.79M |
| Selling, General, and Administrative Expenses | 33.14M | 22.72M | 28.77M | 25.62M |
| Research & Development | 11.56M | 6.98M | 4.76M | 6.80M |
| Operating Income before D & A (EBITDA) | 40.46M | 19.14M | -12.05M | -2.63M |
| Depreciation & Amortization | 7.19M | 7.87M | 7.47M | 4.55M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | -2.12M | -11.72M | -5.86M | -177.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 45.70M | 22.92M | -23.79M | -7.06M |
| Interest Expense | 4.39M | 942.00K | 1.52M | 870.00K |
| Pre-Tax Income | 41.31M | 21.98M | -25.30M | -7.94M |
| Income Taxes | -1.71M | 152.00K | 2.00K | 4.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 43.01M | 21.82M | -25.31M | -7.94M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 43.01M | 21.82M | -25.31M | -7.94M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 43.01M | 21.82M | -25.31M | -7.94M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
43.01M | 21.82M | -25.31M | -7.94M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 43.01M | 21.82M | -25.31M | -7.94M |
| Basic EPS from Continuing Ops. | 0.45 | 0.24 | -0.28 | -0.09 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.45 | 0.24 | -0.28 | -0.09 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.45 | 0.24 | -0.28 | -0.09 |
| Basic Normalized Net Income/Share | 0.45 | 0.24 | -0.28 | -0.09 |
| EPS fr Continuing Ops. | 0.41 | 0.22 | -0.28 | -0.09 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.41 | 0.22 | -0.28 | -0.09 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.41 | 0.22 | -0.28 | -0.09 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.41 | 0.22 | -0.28 | -0.09 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with AKRX
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 16
- UserGFNN Stockdiagnostics 11
- Userpharmacy
- UserGFNN Stockdiagnostics 4
- UserDIGGITY PORTFOLIO
- UserGFNN Stockdiagnostics
- ContributorStocks At New 52-Week Highs...
- UserDivatrades
- Contributor5 Stocks Under-$10 Setting ...
- UserMister 600
Latest AKRX Headlines from TheStreet
- Akorn Stock Hits New 52-Week High (AKRX) 05.30.12 | 02:05 pm
- 3 Stocks Hit 52-Week Highs 05.15.12 | 02:05 pm
- Akorn Stock Hits New 52-Week High (AKRX) 05.15.12 | 09:05 am
- Akorn Reaches New 52-Week High (AKRX) 02.29.12 | 10:02 am
- Akorn Rises On Unusually High Volume (AKRX) 02.13.12 | 04:02 pm
- 3 Stocks Hitting 52-Week Highs: Akorn, Sunoco Logistics, Cincinnati Financial 02.10.12 | 02:02 pm
- Akorn Reaches New 52-Week High (AKRX) 02.10.12 | 12:02 pm
- Akorn Reaches New 52-Week High (AKRX) 02.01.12 | 09:02 am
- Akorn Reaches New 52-Week High (AKRX) 12.19.11 | 10:12 am
- 6 Stocks at New 52-Week Highs 12.13.11 | 01:12 pm
Press Releases for AKRX
- Akorn Reports Record First Quarter 2012 Financial Results - Business Wire 05.08.12 | 06:05 am
- Akorn Announces The Approval And Launch Of Generic Vancocin® - Business Wire 04.10.12 | 06:04 am
- Brinson Patrick Securities Initiates Research Coverage Of Akorn, Inc. - PR Newswire 03.22.12 | 03:03 pm
- Akorn Reports 2011 Fourth Quarter And Year-End Financial Results - Business Wire 03.06.12 | 07:03 am
- Akorn Announces The Appointment Of Dr. Adrienne Graves, Ph.D. To Its Board Of Directors - Business Wire 03.05.12 | 08:03 pm
- Akorn Completes The Acquisition Of Certain Assets Of Kilitch Drugs In India - Business Wire 02.28.12 | 07:02 pm
- Akorn Provides Financial Guidance For 2012 - Business Wire 01.17.12 | 07:01 am
- Akorn Acquires Three Hospital-Based Branded Injectables From Lundbeck - Business Wire 12.22.11 | 01:12 pm
- Akorn Reports Record Third Quarter 2011 Financial Results - Business Wire 11.01.11 | 07:11 am
- Akorn Enters Into An Agreement To Acquire Certain Assets Of Kilitch Drugs In India - Business Wire 10.06.11 | 12:10 am
Partner Headlines for AKRX
- Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Press Releases - Zacks 02.08.12 | 09:02 am
- Akorn, Inc. - Momentum - Zacks 02.08.12 | 01:02 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.20.12 | 09:01 am
- End-of-Day Market Summary for December 23, 2011 - Benzinga 12.23.11 | 04:12 pm
- Hearing Akorn Recent Weakness Attributed to FDA Inspection Letter - Benzinga 12.23.11 | 11:12 am
- Akorn Acquires Three Hospital-Based Branded Injectables from Lundbeck; Expected To Add Approximately $30-$35M in 2012 - Benzinga 12.22.11 | 01:12 pm
- Piper Jaffray Maintains Overweight, $12 Target on Akorn - Benzinga 12.15.11 | 09:12 am
- Akorn, Inc - Aggressive Growth - Zacks 11.11.11 | 01:11 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.03.11 | 09:11 am
- These NASDAQ Rockets Should Be In Your Portfolio - Seeking Alpha 10.19.11 | 09:10 am
